BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $102,448,324 | -15.7% | 2,009,973 | -10.9% | 2.27% | -25.3% |
Q3 2022 | $121,563,000 | -12.9% | 2,257,019 | +3.9% | 3.04% | -12.9% |
Q2 2022 | $139,573,000 | -18.6% | 2,173,019 | -1.7% | 3.49% | +0.6% |
Q1 2022 | $171,444,000 | -8.5% | 2,211,036 | +1.3% | 3.47% | -13.1% |
Q4 2021 | $187,339,000 | +7.4% | 2,182,422 | +0.7% | 3.99% | +26.2% |
Q3 2021 | $174,350,000 | +85.2% | 2,167,722 | +85.4% | 3.16% | +103.1% |
Q2 2021 | $94,136,000 | -19.0% | 1,169,387 | -15.1% | 1.56% | -20.9% |
Q1 2021 | $116,220,000 | +159.2% | 1,377,998 | +146.6% | 1.97% | +91.5% |
Q4 2020 | $44,841,000 | +320.4% | 558,832 | +321.4% | 1.03% | +206.9% |
Q3 2020 | $10,666,000 | +61.4% | 132,623 | +72.8% | 0.34% | +84.1% |
Q2 2020 | $6,607,000 | -83.1% | 76,738 | -84.1% | 0.18% | -82.9% |
Q1 2020 | $39,197,000 | +125.7% | 482,786 | +127.7% | 1.07% | +579.0% |
Q2 2019 | $17,367,000 | -77.3% | 212,055 | -77.5% | 0.16% | -77.0% |
Q1 2019 | $76,495,000 | +32.5% | 940,778 | +7.3% | 0.68% | +22.2% |
Q4 2018 | $57,724,000 | – | 877,001 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |